Present role of sublingual immunotherapy in allergic diseases;Aktueller stellenwert der sublingualen immuntherapie bei allergischen krankheiten

Allergo Journal

Volumn 16, Issue 7, 2007, Pages 492-500

  Kleine Tebbe, Jörg ^a   Bachert, Claus ^b   Bergmann, Karl Christian ^c   Bieber, Thomas ^d   Brehler, Randolf ^e   Friedrichs, Frank ^f   Fuchs, Thomas ^g   Klimek, Ludger ^h   Kopp, Matthias V ⁱ   Lepp, Ute ^j   Przybilla, Bernhard ^k   Rebien, Wolfgang ^l   Renz, Harald ^m   Saloga, Joachim ⁿ   Simon, Jan ^o   Virchow, Johann Christian ^p   Wedi, Bettina ^q   Werfel, Thomas ^q   Worm, Margitta ^c  

^a Allergie und Asthma Zentrum Westend   (Germany)

^b GHENT UNIVERSITY   (Belgium)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f Kinderarztpraxis   (Germany)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h ZENTRUM FÜR RHINOLOGIE UND ALLERGOLOGIE   (Germany)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j Herz Lungen Praxis Stade   (Germany)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l Kinderarztpraxis   (Germany)

^m PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁿ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^o UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^p ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^q HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

Allergenspecific immunotherapy; Allergic diseases; Sublingual therapy

Indexed keywords

ALLERGEN;

ALLERGIC DISEASE; ARTICLE; CLINICAL STUDY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; SYMPTOM;

EID: 36248937050     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03361666     Document Type: Article

References (41)

1. Allam JP, Niederhagen B, Bucheler M, Appel T, Betten H, Bieber T, Berge S, Novak N. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 2006; 61: 166-72
2. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E. Standards for practical allergen-specific immunotherapy. Allergy 2006; 61 (Suppl 82): 1-20
3. Anonymus. "Gräsertablette" Grazax. Arznei-Telegramm 2006; 37: 120
4. Berto P, Passalacqua G, Crimi N, Frati F, Ortolani C, Senna G, Canonica GW. Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Ann Allergy Asthma Immunol 2006; 97: 615-21
5. Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-334
6. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004; 59: 498-504
7. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007: CD001936
8. Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005; 60: 801-7
9. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117: 1021-35
10. Dahl R, Kapp A, Colombo G, Monchy JG de, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434-40
11. Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, André C, de Beaumont O, Melac M. Optimal dose, efficacy and safety of once-daily sublingual immunotherapy with a five-grass-pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007, in press
12. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75
13. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 802-9
14. Frew AJ, Powell RJ, Corrigan CJ, Durham SR. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 319-25
15. Ippoliti F, Santis W De, Volterrani A, Lenti L, Canitano N, Lucarelli S, Frediani T. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003; 14: 216-21
16. Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59: 45-53
17. Kleine-Tebbe J. A bright future for sublingual immunotherapy - contra. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2006; 95: 242-50, discussion 250-2
18. Kleine-Tebbe J, Bergmann K-C, Bufe A, Friedrichs F, Fuchs T, Hirsch T, Klimek L, Lepp U, Przybilla B, Rakoski J, Rebien W, Saloga J, Schultze-Werninghaus G, Virchow J-C. Aktueller Stellenwert der sublingualen Immuntherapie bei allergischen Krankheiten. Allergo J 2004; 13: 430-4
19. Kleine-Tebbe J, Bergmann K-C, Friedrichs F, Fuchs T, Jung K, Klimek L, Kühr J, Lässig W, Niggemann B, Rakoski J, Rebien W, Renz H, Saloga J, Simon J, Sitter H, Virchow J-C, Worm M. Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J 2006; 15: 56-74
20. Kleine-Tebbe J, Ribel M, Herold DA. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 2006; 61: 181-4
21. La Rosa M, Ranno C, André C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999; 104: 425-32
22. Larsen TH, Poulsen LK, Melac M, Combebias A, Andre C, Malling HJ. Safety and tolerability of grass pollen tablets in sublingual immunotherapy - a phase-1 study. Allergy 2006; 61: 1173-6
23. Malling HJ. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002; 2: 523-31
24. Malling HJ, Lund L, Ipsen H, Poulsen L. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets. J Investig Allergol Clin Immunol 2006; 16: 162-8
25. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-900
26. Niu CK, Chen WY, Huang JL, Lue KH, Wang JY. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. Respir Med 2006; 100: 1374-83
27. Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, Staple SQ, Aalberse RC, Till SJ, Durham SR. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004; 172: 3252-9
28. Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, Marco E De, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114: 851-7
29. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000; 55: 842-9
30. Pajno GB, Vita D, Parmiani S, Caminiti L, La Grutta S, Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003; 33: 1641-7
31. Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, Canonica GW. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006; 97: 141-8
32. Pfaar O, Klimek L. Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind placebo-controlled trial. Ann Allergy Asthma Immunol 2007: in press
33. Pham-Thi N, Blic J de, Scheinmann P. Sublingual immunotherapy in the treatment of children. Allergy 2006; 61 (Suppl 81):7-10
34. Röder E, Berger MY, Hop WC, Bernsen RM, Groot H de, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007; 119: 892-8
35. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004; 59: 1285-93
36. Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Vaccine 2007; 25: 957-64
37. Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen. Band III: Über-, Unter- und Fehlversorgung. III.2: Ausgewählte Erkrankungen: Ischämische Herzkrankheiten, Schlaganfall und chronische, obstruktive Lungenkrankheiten. Baden-Baden: Nomos, 2002 (http://www.svr-gesundheit.de)
38. Schädlich PK, Brecht JG. Economic evalutation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany. Pharmocoeconomics 2000; 17: 37-52
39. Schwabe U, Paffrath D, Hrsg. Arzneiverordnungs-Report 2006. Berlin - Heidelberg - New York: Springer, 2007
40. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003: CD002893
41. Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis. Allerg Immunol (Paris) 2006; 38: 355-60